Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United ...
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...
The US Food and Drug Administration approved the marketing of 20 Zyn products to adults, the first time it has authorized ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
FDA authorizes the marketing of 20 Zyn products because they pose fewer health risks than cigarettes and most smokeless products Shares of Philip Morris International ... company's Zyn nicotine ...
WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit ...
Shares of Philip Morris International Inc. extended their ... authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches. The FDA made clear, however, that the marketing ...